drugset / Trial / NCT02120222
Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
NaSingle-groupOpen-labelTreatment
Summary
This phase I clinical trial studies the side effects of selinexor in treating patients with melanoma that cannot be removed by surgery. Drugs used in chemotherapy, such as selinexor, may stop the growth of tumor cells, by stopping them from dividing.
Timeline
- Start
- 2014-08-22
- Primary completion
- 2018-04-08
- Completion
- 2018-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selinexor | Other / unclassified | — | Oral |